Clinical Trials Logo

Clinical Trial Summary

This is an observational, multicenter study to determine the prevalence of Cerebrotendinous Xanthomatosis (CTX) in patient populations diagnosed with early-onset idiopathic bilateral cataracts. Patients who are potentially eligible for study participation will be identified through a chart review of patients who were seen at each study site prior to that site's initiation, or by entering care at the site while the site is participating in the trial.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02638220
Study type Observational
Source Retrophin, Inc.
Contact Retrophin Medical Information
Phone 1-877-659-5518
Email medinfo@retrophin.com
Status Recruiting
Phase
Start date September 2015
Completion date December 2018

See also
  Status Clinical Trial Phase
Recruiting NCT01613898 - Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis N/A